An in-house study of inflammatory cytokines in EDS / POTS / Dysautonomia patients revealed the involvement of inflammation in many of these patients, dramatically altering the approach to evaluation and treatment.
An in-house study of six patients with EDS / POTS / Dysautonomia and vascular fibrosis run to find out if abnormal lipo(a) was the cause of their vascular abnormalities. Normal levels were found, so research quickly moved in other directions.
An in-house study of 21 patients with EDS / POTS / Dysautonomia, studying the potential involvement of IIH (Idiopathic Intracranial Hypertension) or IIHWOP (Idiopathic Intracranial Hypertension Without Papilledema), and the effect of acetazolamide (Diamox) on...
“EDS / POTS / Dysautonomia: evaluation of 165 symptoms and signs”“Chronic Fatigue Syndrome: evaluation of 165 symptoms and signs””Lyme Disease: evaluation of 165 symptoms and signs”